GlassScriptPhysician profile
George L Marks
NPI 1578589602
$2,505.67
in general payments reported to CMS, 2019-2025
13 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $49.97 · 2021: $252 · 2022: $341 · 2023: $443 · 2024: $526 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,223.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $587.61 | 2019-2024 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $463.65 | 2023-2025 | Dupixent |
| Baxter Healthcare | $338.16 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Cardiac Ambulatory Monitor |
| Pfizer INC. | $271.40 | 2019-2025 | |
| Viiv Healthcare Company | $189.38 | 2019-2025 | Apretude |
| Gilead Sciences, INC. | $171.31 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $167.21 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $116.56 | 2019 | |
| Abbvie INC. | $112.06 | 2019 | |
| Philips North America LLC | $25.31 | 2025 | Disposable Vest |
| Lantheus Medical Imaging, INC. | $22.53 | 2024 | |
| Inogen, INC. | $22.34 | 2022 | |
| Ibsa Pharma INC. | $18.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Marks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.